Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 9354 matches for

Nuffield Department of Women's & Reproductive Health sits within the Medical Sciences Division of the University of Oxford. The department encompasses multi-disciplinary research across four overarching themes; Cancer, Global Health, Maternal & Fetal Health and Reproductive Medicine & Genetics

The Impact of AI on Healthcare: Examining ChatGPT's Role

AI is revolutionising healthcare globally, with technologies like ChatGPT now at the forefront. ChatGPT can generate text that sounds remarkably human—so much so that humans cannot discern between text written by ChatGPT and that produced by humans. People worldwide use it for tasks ranging from managing finances to writing poetry, often with impressive results. Recently, however, its use in providing medical advice has raised significant concerns.

Oxford Science Festival Session this Tuesday

Join us at the Oxford Science and Ideas Festival next Tuesday!

Prof. Ahmed and Dr. Zaarour secure funds to develop ovarian cancer vaccine

Professor Ahmed Ahmed and Dr Nancy Zaarour have received funding from Cancer Research UK to undertake preclinical testing of a preventative vaccine for ovarian cancer. The vaccine would teach the immune system to recognise and attack the earliest stages of ovarian cancer. The team will receive up to £600,000 for the study over the next three years to support lab research into the vaccine.

NDWRH Celebrates Athena Swan Gold Award Success

The Nuffield Department of Women's & Reproductive Health at the University of Oxford (NDWRH) is proud to announce that on Monday 23 September 2024, the department was awarded the prestigious Athena Swan Gold Award. This achievement follows a rigorous and substantial application process, reaffirming the department’s commitment to gender equality and the promotion of diversity within science and higher education.

Postdoc Appreciation Week (16 - 20 September)

This week, we celebrated Postdoc Appreciation Week by honouring the contributions of our talented postdocs at the University of Oxford. Their work and commitment makes a huge difference to our research projects and raising the profile of women's health issues.

FemTech Forward 2024: Transforming Women’s Health with Tech

The FemTech Forward Conference 2024 marked the first conference in this field in Oxford. Led by Christiane Hagel, the event gathered over 80 participants from diverse disciplines to explore advancements in women's health technology. Amongst other speakers were Professor Christian Becker and Dr Tatjana Gibbons.

Human Endometrial Map Uncovers Hidden Health Clues

The inner lining of the uterus, the endometrium, has been mapped during multiple phases of the menstrual cycle, starting to shed new light on the cells and processes involved and their potential role in conditions such as endometriosis.

Oxford part of new international Pioneer Centre for medical data research

The University of Oxford has joined forces with Aarhus University and the University of Copenhagen to create a new Pioneer Centre that will become a significant international partner for data-driven medical research. The Pioneer Centre is anchored at Aarhus University with hub sites at each of the three universities and with a total grant of DKK 250 million.

Professor Chris Redman (30 Nov 1941 - 13 Aug 2024)

It is with deep sadness that we share the news of the passing of our esteemed colleague, Professor Christopher Redman. Chris was a global pioneer in maternity care. A physician by training, he was among the first to recognise the critical importance of both pre-existing medical conditions and diseases unique to pregnancy, particularly pre-eclampsia, in ensuring the safety of mother and child. His work in this area made him a world leader.

Celebrating Innovation: Proposed sale of the Clinical AI Business to GE HealthCare for £40.5 million

We are delighted to celebrate the remarkable achievements of Intelligent Ultrasound, a pioneering company that began as a spin-out from the University of Oxford in 2012. Co-founded by Prof. Alison Noble and Prof. Aris Papageorghiou, Intelligent Ultrasound has made significant strides in transforming ultrasound technology through cutting-edge artificial intelligence (AI).

New Research Identifies Potential Genetic Marker for Gabapentin Efficacy in Treating Chronic Pelvic Pain

A recent study on chronic pelvic pain (CPP) at the Nuffield Department of Women’s & Reproductive Health, has been published in Science Direct.

Olympic winners!

Huge congratulations to MSc Research student, Charlie Elwes who won gold this week in the men’s eights. And a big shoutout to Heidi Long, whHeidi Long (due to be starting an MRes with Prof. Williams) who won Bronze in the women’s eights.

Heat Exposure and Hormones: Exacerbating the Health Impacts of Climate Change

Today, our article in Nature Reviews Endocrinology highlighted the urgent necessity for expanded research into the impact of heat exposure on the endocrine system.

Future of Oxford lactation research centre secured with £9.12 million donation

Official Press release: A £9.12 million gift from the Family Larsson-Rosenquist Foundation has endowed an Oxford University research centre investigating the role of hormones in human milk production.

AI offers potential to transform Pregnancy Scans in Africa

Dr. Aris Papageorghiou, co-founder of Intelligent Ultrasound, Principal Investigator and Global Health theme lead at the Nuffield Dept of Women’s & Reproductive Health, is at the forefront of an exciting project that is transforming pregnancy care in Africa. The AI-based ScanNav FetalCheck ultrasound software, currently being tested in Uganda, promises to revolutionise prenatal care in low-resource settings by enabling scans without the need for specialists.

Children's BMI and LDL-C (cholesterol) are major risk factors for adult cardiovascular disease.

A groundbreaking study, recently published in JAMA Network Open, has uncovered the significant contributions of both childhood and adulthood cardiovascular risk factors to the development of cardiovascular disease (CVD) in middle age. The research tracked 10,634 participants from the US, Finland, and Australia from childhood (1970s-1990s) until 2019. The mean age at childhood was 13.3 years, and the mean age for adulthood was 32.3 years.

Major UK Study Reveals Shifting Trends and Persistent Challenges in Heart Disease Over the Last 20 Years

A groundbreaking new study has shed light on how the landscape of heart disease has evolved in the UK over the past two decades. Researchers analyzed electronic health records from the Clinical Practice Research Datalink (CPRD GOLD and Aurum), encompassing a representative cohort of 22 million individuals. This included 1,650,052 people newly diagnosed with at least one cardiovascular disease (CVD) between 2000 and 2019, with an average age of 70.5 years, of whom 48% were women.

Continuing Positive Results for Imaging of Endometriosis with 99mTc-Maraciclatide

Further data has been presented from the “Detecting Endometriosis expressed integrins using technetium-99m” (DETECT) imaging study, indicating that 99mTc-maraciclatide is capable of imaging superficial peritoneal endometriosis, the earliest stage of the disease.

International Recognition for NDWRH Extracellular Vesicle Work

Associate Professor at the Nuffield Dept of Women's & Reproductive Health elected Secretary General and recognised for special award.

New Funding Boosts Innovative Research for Early-Onset Preeclampsia Screening

Our development of the ExoCounter assay, which detects placental small extracellular vesicles in maternal blood, offers a promising and resource-efficient method for screening the early-onset variant of Preeclampsia. This project is supported by global collaboration and funding to enhance its application in diverse populations.

Load More